• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Medivis wins FDA clearance for AR cranial navigation platform for neurosurgery guidance

Medivis wins FDA clearance for AR cranial navigation platform for neurosurgery guidance

December 16, 2025 By Sean Whooley

Medivis Cranial Navigation AR Guidance (1)
The Cranial Navigation platform in use from the first-person view. [Image courtesy of Medivis]
Medivis announced today that it received FDA 510(k) clearance for its augmented reality (AR)-powered Cranial Navigation platform.

The company said clearance makes Cranial Navigation the world’s first AR system cleared for intraoperative guidance in cranial neurosurgery. It marks the company’s second major FDA clearance this year, following the launch of its Spine Navigation platform.

New York-based Medivis’ FDA milestones go as far back as 2019, when the agency cleared its SurgicalAR platform. At that time, the company also touted strategic partnerships with Verizon and Microsoft.

The Cranial Navigation platform uses AR to spatially map patient imaging within the operative field. Medivis said it gives surgeons a clear, real-time view of critical anatomy and planned trajectories. It designed the approach to support faster, more confident decision-making during cranial procedures. The platform can also minimize workflow disruption and reduce dependence on external monitors.

Medivis said its platform’s portable design also enables reliable image guidance in settings where conventional systems fail. That includes the intensive care unit (ICU). This extends image-guided precision to a wider range of clinical environments, helping to reduce misplacements, improve patient safety, accelerate life-saving interventions and raise the standard of care in neurosurgery.

Cranial Navigation combines proprietary computer vision, segmentation, real-time data analysis and advanced image processing. Lightweight AR hardware helps keep critical information in the surgeon’s line of sight and reduces attention shifts away from the operative field. The platform streamlines data-driven decision-making in routine settings and previously inaccessible environments, too, Medivis says.

“For the first time, neurosurgeons can perform cranial procedures using augmented reality – merging the digital and physical worlds with high-accuracy guidance,” said Dr. Osamah Choudhry, CEO and co-founder of Medivis. “This is a profound milestone not only for Medivis, but for the entire field of neurosurgery. With this clearance, we’re bringing image-guided navigation to the ICU, where it hasn’t been possible before, giving clinicians greater precision at the bedside and helping support safer care for patients, while paving the way for full integration into operating rooms.”

Filed Under: 510(k), Artificial Intelligence (AI), Food & Drug Administration (FDA), Health Technology, Machine Learning (ML), Neurological, Regulatory/Compliance, Software / IT, Surgical Tagged With: Medivis

More recent news

  • Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
  • Autonomix taps former Medtronic FDA counsel head for board of directors
  • Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
  • Science Corp. names president as it looks to roll out vision-restoring implant
  • Mindray looks to fill hospital ventilator gap left by Philips’ exit

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy